Proposed Data Collection Submitted for Public Comment and Recommendations, 18459-18460 [2017-07902]

Download as PDF Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices of seagrass, 650 acres of coastal wetlands, 14 acres of coastal uplands, and 1.8 acres of freshwater wetlands. Habitat restoration includes invasive removal, sediment contouring, and native plantings. Additional information on the TBEP restoration elements, including metrics of success, response to science reviews and more is available in an activityspecific appendix to the FPL, which can be found at https:// www.restorethegulf.gov. (Please see the table on page 25 of the FPL and click on: Tampa Bay Estuary Program, Implementation.) Will D. Spoon, Program Analyst, Gulf Coast Ecosystem Restoration Council. BILLING CODE 6560–58–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–17–0004: Docket No. CDC–2017– 0035] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the revision of the National Disease Surveillance Program II Disease Summaries information collection. These surveillance data are essential on the local, state, and federal levels for measuring trends in diseases, evaluating the effectiveness of current preventive strategies, and determining the need to modify current preventive measures. DATES: Written comments must be received on or before June 19, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC–2017– 0035 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. jstallworth on DSK7TPTVN1PROD with NOTICES VerDate Sep<11>2014 15:06 Apr 18, 2017 Jkt 241001 Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: [FR Doc. 2017–07720 Filed 4–18–17; 8:45 am] SUMMARY: • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 18459 resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project National Disease Surveillance Program II Disease Summaries (OMB Control Number 0920–0004, Expiration Date 10/31/2017)—Revision—National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC requests a three-year approval for the revision of the National Disease Surveillance Program II Disease Summaries information collection. As with the previous approval, these data are essential for measuring trends in diseases, evaluating the effectiveness of current preventive strategies, and determining the need to modify current preventive measures. The following diseases in this surveillance program are Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, Waterborne Outbreaks and Enteroviruses. Proposed revisions include form consolidation, minor revised language and rewording to improve clarity and readability of the data collection forms and the discontinuation of multiple previously approved influenza collection instruments, and the National Respiratory & Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC 55.83). CDC requests the use of a new form, Suspect Respiratory Virus Patient Form, to assist health departments and clinical sites when they submit specimens to the CDC lab for viral pathogen identification. The data will enable rapid detection and characterization of outbreaks of known pathogens, as well as potential newly emerging viral pathogens. The total burden estimate for all collection instruments in this revision request is 24,804. The frequency of response for each form will depend on the disease and surveillance need. This represents a 7,117 burden hour reduction since last approval. This E:\FR\FM\19APN1.SGM 19APN1 18460 Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices reduction in burden hours is attributed primarily to the discontinuation of previously approved forms and formatting changes to existing forms. ESTIMATED ANNUALIZED BURDEN HOURS Form name Epidemiologist ............... Epidemiologist ............... NORS Foodborne Disease Transmission_Person to Person Disease Transmission_Animal Contact_Environmental Contamination_Unknown Transmission Mode_52.13. WHO COLLABORATING CENTER FOR INFLUENZA Influenza Virus Surveillance. U.S. WHO Collaborating Laboratories Influenza Testing Methods Assessment. U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly_CDC 55.20. U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Workfolder 55.20E. Influenza-Associated Pediatric Mortality Case Report Form. Human Infection with Novel Influenza A Virus Case Report Form. Human Infection with Novel Influenza A Virus Severe Outcomes. Novel Influenza A Virus Case Screening Form .. Antiviral Resistant Influenza Infection Case Report Form. National Respiratory & Enteric Virus Surveillance System (NREVSS) (55.83A, B, D) (electronic). National Enterovirus Surveillance Report: (CDC 55.9) (electronic). National Adenovirus Type Reporting System (NATRS). Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form. Viral Gastroenteritis Outbreak Submission Form NORS Waterborne Disease Transmission Form_52.12.. Influenza Virus (Electronic, Year Round), PHLIP_HL7 messaging Data Elements. Influenza virus (electronic, year round) (PHIN– MS). Suspect Respiratory Virus Patient Form ............. Total ........................ .............................................................................. Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Epidemiologist ............... Number of responses per respondent Number of respondents Type of respondent 37 20/60 666 53 52 10/60 460 113 1 10/60 19 1,800 52 10/60 15,600 1,800 1 5/60 150 57 2 30/60 57 57 2 30/60 57 57 1 1.5/60 86 57 57 1 3 15/60 30/60 15 86 550 52 15/60 7,150 20 12 15/60 60 13 4 15/60 13 57 3 25/60 72 20 57 5 1 5/60 20/60 9 19 57 52 5/60 247 3 52 5/60 13 10 5 30/60 25 ........................ ........................ ........................ 24,804 DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–07902 Filed 4–18–17; 8:45 am] [60Day–17–17ABC; Docket No. CDC–2017– 0033] Centers for Disease Control and Prevention Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. jstallworth on DSK7TPTVN1PROD with NOTICES AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of SUMMARY: VerDate Sep<11>2014 15:06 Apr 18, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4703 Total burden hours 54 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P Average burden per response (in hours) Sfmt 4703 government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled ‘‘Zika Postpartum Emergency Response Survey (ZPER), Puerto Rico, 2017.’’ DATES: Written comments must be received on or before June 19, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC–2017– 0033 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 82, Number 74 (Wednesday, April 19, 2017)]
[Notices]
[Pages 18459-18460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07902]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-17-0004: Docket No. CDC-2017-0035]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the revision of 
the National Disease Surveillance Program II Disease Summaries 
information collection. These surveillance data are essential on the 
local, state, and federal levels for measuring trends in diseases, 
evaluating the effectiveness of current preventive strategies, and 
determining the need to modify current preventive measures.

DATES: Written comments must be received on or before June 19, 2017.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0035 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note:  All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    National Disease Surveillance Program II Disease Summaries (OMB 
Control Number 0920-0004, Expiration Date 10/31/2017)--Revision--
National Center for Immunization and Respiratory Diseases, Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three-year approval for the revision of the National 
Disease Surveillance Program II Disease Summaries information 
collection.
    As with the previous approval, these data are essential for 
measuring trends in diseases, evaluating the effectiveness of current 
preventive strategies, and determining the need to modify current 
preventive measures. The following diseases in this surveillance 
program are Influenza Virus, Caliciviruses, Respiratory and Enteric 
Viruses, Foodborne Outbreaks, Waterborne Outbreaks and Enteroviruses. 
Proposed revisions include form consolidation, minor revised language 
and rewording to improve clarity and readability of the data collection 
forms and the discontinuation of multiple previously approved influenza 
collection instruments, and the National Respiratory & Enteric Virus 
Surveillance System (NREVSS) Laboratory Assessment (CDC 55.83). CDC 
requests the use of a new form, Suspect Respiratory Virus Patient Form, 
to assist health departments and clinical sites when they submit 
specimens to the CDC lab for viral pathogen identification. The data 
will enable rapid detection and characterization of outbreaks of known 
pathogens, as well as potential newly emerging viral pathogens.
    The total burden estimate for all collection instruments in this 
revision request is 24,804. The frequency of response for each form 
will depend on the disease and surveillance need. This represents a 
7,117 burden hour reduction since last approval. This

[[Page 18460]]

reduction in burden hours is attributed primarily to the 
discontinuation of previously approved forms and formatting changes to 
existing forms.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent      (in hours)         hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist.................................  NORS Foodborne Disease                               54              37           20/60             666
                                                  Transmission_Person to Person Disease
                                                  Transmission_Animal
                                                  Contact_Environmental
                                                  Contamination_Unknown Transmission
                                                  Mode_52.13.
Epidemiologist.................................  WHO COLLABORATING CENTER FOR INFLUENZA               53              52           10/60             460
                                                  Influenza Virus Surveillance.
Epidemiologist.................................  U.S. WHO Collaborating Laboratories                 113               1           10/60              19
                                                  Influenza Testing Methods Assessment.
Epidemiologist.................................  U.S. Outpatient Influenza-like Illness            1,800              52           10/60          15,600
                                                  Surveillance Network (ILINet)
                                                  Weekly_CDC 55.20.
Epidemiologist.................................  U.S. Outpatient Influenza-like Illness            1,800               1            5/60             150
                                                  Surveillance Network (ILINet)
                                                  Workfolder 55.20E.
Epidemiologist.................................  Influenza-Associated Pediatric                       57               2           30/60              57
                                                  Mortality Case Report Form.
Epidemiologist.................................  Human Infection with Novel Influenza A               57               2           30/60              57
                                                  Virus Case Report Form.
Epidemiologist.................................  Human Infection with Novel Influenza A               57               1          1.5/60              86
                                                  Virus Severe Outcomes.
Epidemiologist.................................  Novel Influenza A Virus Case Screening               57               1           15/60              15
                                                  Form.
Epidemiologist.................................  Antiviral Resistant Influenza Infection              57               3           30/60              86
                                                  Case Report Form.
Epidemiologist.................................  National Respiratory & Enteric Virus                550              52           15/60           7,150
                                                  Surveillance System (NREVSS) (55.83A,
                                                  B, D) (electronic).
Epidemiologist.................................  National Enterovirus Surveillance                    20              12           15/60              60
                                                  Report: (CDC 55.9) (electronic).
Epidemiologist.................................  National Adenovirus Type Reporting                   13               4           15/60              13
                                                  System (NATRS).
Epidemiologist.................................  Middle East Respiratory Syndrome (MERS)              57               3           25/60              72
                                                  Patient Under Investigation (PUI)
                                                  Short Form.
Epidemiologist.................................  Viral Gastroenteritis Outbreak                       20               5            5/60               9
                                                  Submission Form.
Epidemiologist.................................  NORS Waterborne Disease Transmission                 57               1           20/60              19
                                                  Form_52.12..
Epidemiologist.................................  Influenza Virus (Electronic, Year                    57              52            5/60             247
                                                  Round), PHLIP_HL7 messaging Data
                                                  Elements.
Epidemiologist.................................  Influenza virus (electronic, year                     3              52            5/60              13
                                                  round) (PHIN-MS).
Epidemiologist.................................  Suspect Respiratory Virus Patient Form.              10               5           30/60              25
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............          24,804
--------------------------------------------------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-07902 Filed 4-18-17; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.